Skip to main content

Edaravone comment watch save
BreastfeedingPediatric

  • FDA APPROVAL DATE: 05/05/2017
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known
  • PREGNANCY: May cause fetal toxicity based on findings in animal studies

Radicava contains sodium bisulfite which may cause allergic type reactions.

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top